Resistance to Targeted Therapies in Breast Cancer - Resistance to Targeted Anti-Cancer Therapeutics -  - Libros - Springer International Publishing AG - 9783319888910 - 23 de junio de 2018
En caso de que portada y título no coincidan, el título será el correcto

Resistance to Targeted Therapies in Breast Cancer - Resistance to Targeted Anti-Cancer Therapeutics Softcover Reprint of the Original 1st 2017 edition

Precio
Mex$ 1.949
sin IVA

Pedido desde almacén remoto

Entrega prevista 14 - 24 de sep.
Añadir a tu lista de deseos de iMusic

Aún no valorado

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling).


184 pages, 12 Illustrations, black and white; XV, 184 p. 12 illus.

Medios de comunicación Libros     Paperback Book   (Libro con tapa blanda y lomo encolado)
Publicado 23 de junio de 2018
ISBN13 9783319888910
Editores Springer International Publishing AG
Páginas 184
Dimensiones 150 × 220 × 10 mm   ·   290 g
Lengua Alemán  
Editor Prosperi, Jenifer R.

Más del mismo editor